查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825626

2025年全球生物防御市场报告

Biodefense Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年生物防御市场将强劲成长，到 2029 年将达到 281 亿美元，复合年增长率为 8.6%。预测期内的成长可归因于新感染疾病的不断出现、生物技术的进一步进步、支持全球生物防御工作的国际合作和资金筹措机制的加强、生物防御基础设施的建设和升级、公众对生物防御的认识和教育的提高、支持创新生物防御技术的政策和法律规范的不断发展，以及私营部门对生物防御研发的投资增加。预测期内的主要趋势包括在预测模型、威胁检测和新生物防御工具的开发中使用人工智慧和机器学习；整合远端医疗和远端监控技术以及早发现和管理生物威胁；专注于下一代疫苗和治疗方法的开发；人工智慧主导的药物发现和开发流程；以及改进的基因组监测和数据分析。

未来五年8.6%的成长率预测，较我们先前对该市场的预测略有下降0.5%。这一下降主要源自于美国与其他国家之间关税的影响。关税上调可能会增加美国从法国和南非购买炭疽菌疫苗和便携式生物防护设备的成本，加剧生物恐怖主义应对措施的成本，并限制紧急储备，从而对美国的国家安全构成威胁。由于互惠关税以及不断升级的贸易摩擦和限制对全球经济和贸易的负面影响，关税上调的影响也将更加广泛。

由于新兴感染疾病的持续威胁，生物防御市场预计将持续成长。这些疾病由细菌、病毒、寄生虫和真菌等多种微生物引起，凸显了生物防御领域在病原体控制、快速反应策略、全球协调和准备方面持续面临的挑战。生物防御对于控制感染疾病并减轻其对公共卫生的影响至关重要，因为它可以提高防范能力、早期发现和快速应对生物威胁的能力。例如，世界卫生组织 (WHO) 在 2023 年 11 月估计，2022 年全球结核病病例数约为 1,060 万例，影响全球数百万人。这些反覆出现的威胁正在推动生物防御市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球生物防御：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球生物防御市场：成长率分析
  • 全球生物防御市场表现：规模与成长，2019-2024
  • 全球生物防御市场预测：2024-2029年及2034年规模与成长
  • 全球生物防御：总目标市场（TAM）

第六章 市场细分

  • 全球生物防御市场：按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 炭疽菌
  • 天花
  • 肉毒桿菌中毒
  • 辐射或核
  • 其他类型
  • 全球生物防御市场：生物武器检测设备市场现况及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 采样器
  • 检测器或触发装置
  • 识别符
  • 侦测
  • 其他生物武器侦测装置
  • 全球生物防御市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 门诊治疗中心
  • 其他用途
  • 全球生物防御市场：按炭疽菌类型、实际和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 炭疽菌疫苗
  • 炭疽菌治疗药物
  • 全球生物防御市场：按天花​​类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 天花疫苗
  • 天花抗病毒药物
  • 全球生物防御市场：按肉毒桿菌类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 肉毒桿菌抗毒素
  • 肉毒桿菌疫苗
  • 肉毒桿菌抑制剂
  • 全球生物防御市场：按放射性或核能细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 防辐射药物
  • 医疗措施
  • 全球生物防御市场：按类型（其他）细分、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 赖氨酸
  • 瘟疫
  • 土拉菌病
  • 病毒性出血热
  • 其他生物毒素或生物威胁剂

第七章 区域和国家分析

  • 全球生物防御市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球生物防御市场：依国家、表现及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 生物防御市场：竞争格局
  • 生物防御市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • AstraZeneca Plc
  • GSK plc
  • Gilead Sciences Inc
  • Biogen Inc
  • Novavax Inc
  • Ichor Medical Systems
  • Emergent BioSolutions Inc.
  • Alnylam Pharmaceuticals Inc.
  • Dynavax Technologies
  • Bavarian Nordic
  • Siga Technologies Inc.
  • Elusys Therapeutics Inc.
  • Ology Bioservices
  • Altimmune Inc.
  • Hytest Limited

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年生物防御市场：提供新机会的国家
  • 2029年生物防御市场：细分领域带来新机会
  • 2029年生物防御市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29593u

Biodefense encompasses strategies and measures aimed at safeguarding against biological threats, including intentional releases of pathogens or biotoxins. These efforts involve developing detection systems, vaccines, treatments, and emergency response plans to minimize the impact of biological attacks on public health and safety. Additionally, biodefense includes research and policies to prevent the misuse of biological agents.

The primary types of biodefense include anthrax, smallpox, botulism, radiation or nuclear threats, and others. Anthrax is a severe infectious disease caused by Bacillus anthracis, affecting humans and animals. It can be contracted through skin contact, inhalation, or ingestion of spores. Various biothreat detection devices, such as samplers, detectors, identifiers, assays, and more, are utilized in settings such as hospitals, clinics, ambulatory care centers, and beyond.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The biodefense research report is one of a series of new reports from The Business Research Company that provides biodefense market statistics, including the biodefense industry's global market size, regional shares, competitors with a biodefense market share, detailed biodefense market segments, market trends and opportunities, and any further data you may need to thrive in the biodefense industry. This biodefense market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biodefense market size has grown strongly in recent years. It will grow from $18.55 billion in 2024 to $20.23 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased government investment in biodefense programs and initiatives, strengthening of regulatory frameworks to fast-track the approval of biodefense products and technologies, enhanced collaboration between government agencies, private sector companies, and academic institutions, rising geopolitical tensions and concerns over bioterrorism.

The biodefense market size is expected to see strong growth in the next few years. It will grow to $28.1 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the continued emergence of new infectious diseases, further breakthroughs in biotechnology, strengthening of international collaboration and funding mechanisms to support global biodefense efforts building and upgrading biodefense infrastructure, increasing public awareness and education on biodefense, continued evolution of policies and regulatory frameworks to support innovative biodefense technologies, growing investment from the private sector in biodefense research and development. Major trends in the forecast period include leveraging AI and machine learning for predictive modeling, threat detection, and the development of new biodefense tools, integration of telehealth and remote monitoring technologies for early detection and management of biological threats, focus on the development of next-generation vaccines and therapeutics, AI-driven drug discovery and development processes, improved genomic surveillance and data analytics.

The forecast of 8.6% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. national security by driving up the cost of anthrax vaccines and portable biocontainment units sourced from France and South Africa, exacerbating bioterrorism preparedness costs and limiting emergency stockpiles. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The biodefense market is anticipated to experience growth due to the persistent threat of emerging infectious diseases. These diseases, caused by various microorganisms such as bacteria, viruses, parasites, or fungi, highlight the ongoing challenges in pathogen control, rapid response strategies, global coordination, and readiness within the biodefense sector. Biodefense is crucial for managing infectious diseases by improving preparedness, early detection, and swift response to biological threats, thus mitigating their impact on public health. For example, in November 2023, the World Health Organization (WHO) estimated a global tuberculosis (TB) case count of around 10.6 million in 2022, affecting millions of individuals worldwide. This recurring threat underscores the driving force behind the growth of the biodefense market.

Leading companies in the biodefense sector are actively developing innovative solutions, such as nasal COVID-19 vaccines, to bolster global readiness against biological hazards. Nasal vaccines offer advantages such as easier administration, potential for mucosal immunity, reduced reliance on needles, increased accessibility, and potentially enhanced immune responses. For instance, Bharat Biotech International Limited launched the iNCOVACC Nasal COVID-19 vaccine in January 2023. This vaccine, developed using a recombinant replication-deficient adenovirus vector with a pre-fusion stabilized spike protein, underwent successful phase I, II, and III trials. Administered via nasal drops, it involves a 2-dose series given 4 weeks apart, with 4 drops into each nostril.

In September 2022, Emergent BioSolutions Inc. acquired worldwide rights to the TEMBEXA (brincidofovir) smallpox oral antiviral drug from Chimerix for $238 million. This acquisition underscores Emergent BioSolutions' commitment to advancing public health initiatives and addressing global health threats, particularly against smallpox outbreaks. Chimerix Inc., a biotechnology research company, is known for providing biodefense solutions.

Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals

North America was the largest region in the biodefense market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biodefense market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biodefense market consists of revenues earned by entities by providing services such as threat assessment, surveillance, training, consultation, strategy development, emergency planning, and facility management. The market value includes the value of related goods sold by the service provider or included within the service offering. The biodefense market also includes sales of detection equipment, personal protective gear, vaccines and pharmaceuticals, biological agent identification kits, biocontainment equipment, emergency response kits, biosecurity systems, and communication systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodefense Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biodefense market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodefense ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biodefense market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Anthrax; Smallpox; Botulism; Radiation Or Nuclear; Other Types
  • 2) By Biothreat Detection Device: Samplers; Detectors Or Triggering Devices; Identifiers; Assays; Other Biothreat Detection Devices
  • 3) By Application: Hospitals And Clinics; Ambulatory Care Centers; Other Applications
  • Subsegments:
  • 1) By Anthrax: Bacillus Anthracis Vaccine; Anthrax Therapeutics
  • 2) By Smallpox: Smallpox Vaccine; Antiviral Drugs For Smallpox
  • 3) By Botulism: Botulism Antitoxin; Botulism Vaccine; Botulinum Neurotoxin Inhibitors
  • 4) By Radiation Or Nuclear: Radiation Protection Drugs; Medical Countermeasures
  • 5) By Other Types: Ricin; Plague; Tularemia; Viral Hemorrhagic Fevers; Other Biotoxins Or Biothreat Agents
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co.; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca Plc; GSK plc; Gilead Sciences Inc; Biogen Inc; Novavax Inc; Ichor Medical Systems; Emergent BioSolutions Inc.; Alnylam Pharmaceuticals Inc.; Dynavax Technologies; Bavarian Nordic; Siga Technologies Inc.; Elusys Therapeutics Inc.; Ology Bioservices; Altimmune Inc.; Hytest Limited; XOMA Corporation; Cleveland BioLabs Inc.; Inovio Pharmaceuticals Inc; Dynport Vaccine Company; ViralClear Pharmaceuticals
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biodefense Market Characteristics

3. Biodefense Market Trends And Strategies

4. Biodefense Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biodefense Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biodefense PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biodefense Market Growth Rate Analysis
  • 5.4. Global Biodefense Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biodefense Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biodefense Total Addressable Market (TAM)

6. Biodefense Market Segmentation

  • 6.1. Global Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Anthrax
  • Smallpox
  • Botulism
  • Radiation Or Nuclear
  • Other Types
  • 6.2. Global Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Samplers
  • Detectors Or Triggering Devices
  • Identifiers
  • Assays
  • Other Biothreat Detection Devices
  • 6.3. Global Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Care Centres
  • Other Applications
  • 6.4. Global Biodefense Market, Sub-Segmentation Of Anthrax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacillus Anthracis Vaccine
  • Anthrax Therapeutics
  • 6.5. Global Biodefense Market, Sub-Segmentation Of Smallpox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Smallpox Vaccine
  • Antiviral Drugs For Smallpox
  • 6.6. Global Biodefense Market, Sub-Segmentation Of Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Botulism Antitoxin
  • Botulism Vaccine
  • Botulinum Neurotoxin Inhibitors
  • 6.7. Global Biodefense Market, Sub-Segmentation Of Radiation Or Nuclear, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiation Protection Drugs
  • Medical Countermeasures
  • 6.8. Global Biodefense Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ricin
  • Plague
  • Tularemia
  • Viral Hemorrhagic Fevers
  • Other Biotoxins Or Biothreat Agents

7. Biodefense Market Regional And Country Analysis

  • 7.1. Global Biodefense Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biodefense Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biodefense Market

  • 8.1. Asia-Pacific Biodefense Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biodefense Market

  • 9.1. China Biodefense Market Overview
  • 9.2. China Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biodefense Market

  • 10.1. India Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biodefense Market

  • 11.1. Japan Biodefense Market Overview
  • 11.2. Japan Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biodefense Market

  • 12.1. Australia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biodefense Market

  • 13.1. Indonesia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biodefense Market

  • 14.1. South Korea Biodefense Market Overview
  • 14.2. South Korea Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biodefense Market

  • 15.1. Western Europe Biodefense Market Overview
  • 15.2. Western Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biodefense Market

  • 16.1. UK Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biodefense Market

  • 17.1. Germany Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biodefense Market

  • 18.1. France Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biodefense Market

  • 19.1. Italy Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biodefense Market

  • 20.1. Spain Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biodefense Market

  • 21.1. Eastern Europe Biodefense Market Overview
  • 21.2. Eastern Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biodefense Market

  • 22.1. Russia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biodefense Market

  • 23.1. North America Biodefense Market Overview
  • 23.2. North America Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biodefense Market

  • 24.1. USA Biodefense Market Overview
  • 24.2. USA Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biodefense Market

  • 25.1. Canada Biodefense Market Overview
  • 25.2. Canada Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biodefense Market

  • 26.1. South America Biodefense Market Overview
  • 26.2. South America Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biodefense Market

  • 27.1. Brazil Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biodefense Market

  • 28.1. Middle East Biodefense Market Overview
  • 28.2. Middle East Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biodefense Market

  • 29.1. Africa Biodefense Market Overview
  • 29.2. Africa Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biodefense Market Competitive Landscape And Company Profiles

  • 30.1. Biodefense Market Competitive Landscape
  • 30.2. Biodefense Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Biodefense Market Other Major And Innovative Companies

  • 31.1. AstraZeneca Plc
  • 31.2. GSK plc
  • 31.3. Gilead Sciences Inc
  • 31.4. Biogen Inc
  • 31.5. Novavax Inc
  • 31.6. Ichor Medical Systems
  • 31.7. Emergent BioSolutions Inc.
  • 31.8. Alnylam Pharmaceuticals Inc.
  • 31.9. Dynavax Technologies
  • 31.10. Bavarian Nordic
  • 31.11. Siga Technologies Inc.
  • 31.12. Elusys Therapeutics Inc.
  • 31.13. Ology Bioservices
  • 31.14. Altimmune Inc.
  • 31.15. Hytest Limited

32. Global Biodefense Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biodefense Market

34. Recent Developments In The Biodefense Market

35. Biodefense Market High Potential Countries, Segments and Strategies

  • 35.1 Biodefense Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biodefense Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biodefense Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer